Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.

Authors

Neha Vapiwala

Neha Vapiwala

Abramson Cancer Center, Philadelphia, PA

Neha Vapiwala , Yu-Hui Chen , Steve Y. Cho , Fenghai Duan , Christos Kyriakopoulos , Alicia K. Morgans , Daniel H. Shevrin , Bridget F. Koontz , Rana R. McKay , Evan Y. Yu , Jonathan McConathy , Glenn Liu , David A. Mankoff , Terence Z. Wong , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04423211

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS402)

DOI

10.1200/JCO.2023.41.6_suppl.TPS402

Abstract #

TPS402

Poster Bd #

R6

Abstract Disclosures